Ozempic, Wegovy get new warning over potential vision loss: Should patients be worried?
The US Food and Drug Administration (FDA) is requiring new safety warnings on popular GLP-1 medicines, including Ozempic, Wegovy, Mounjaro and Zepbound, over a potential risk of a rare eye condition